Harrison & Star lands Roche Pegasys account

Roche switched professional agencies for its top-selling hepatitis C therapy Pegasys to Omnicom’s Harrison & Star from echo Torre Lazur, part of Interpublic Group’s McCann Healthcare Worldwide. The move followed a three-way pitch among Harrison & Star, GSW and one other agency. Pegasys is the world’s best-selling treatment for chronic hepatitis C. The drug brought in $1.13 billion in revenue last year, a 17% increase over 2004.
You must be a registered member of MMM to post a comment.